Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Lactobacillus rhamnosus HN001 is a clinically-studied probiotic strain that produces bacteriocins and short-chain fatty acids to inhibit pathogenic bacteria growth. This strain modulates immune cell activity through Toll-like receptor signaling pathways in the intestinal mucosa.
Reported Benefits (Provisional)
Origin & History
Lactobacillus rhamnosus HN001 is a probiotic strain isolated from dairy products. It is recognized for its robust ability to colonize the gut.
Research Narrative (Provisional)
Studies show its positive effects on gut and mental health, but further research is necessary to fully understand its benefits.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains beneficial probiotics. - Supports mental and physical health. - Enhances gut microbiota.
Reported Mechanism (Provisional)
Lactobacillus rhamnosus HN001 produces antimicrobial bacteriocins and lactic acid that create an acidic environment inhibiting pathogenic bacteria like E. coli and Salmonella. The strain activates dendritic cells and stimulates cytokine production through interaction with intestinal epithelial Toll-like receptors 2 and 9. Its metabolites including butyrate and propionate strengthen tight junction proteins and enhance intestinal barrier function.
Clinical Narrative (Provisional)
Multiple randomized controlled trials involving 200-400 participants demonstrate HN001's ability to reduce pathogenic bacteria populations by up to 50% within 4-6 weeks of supplementation. Clinical studies show significant increases in secretory IgA antibody levels and enhanced natural killer cell activity in healthy adults taking 1-10 billion CFU daily. Evidence from pregnancy studies indicates improved maternal immune markers and reduced infant eczema rates, though more large-scale trials are needed to confirm all immune benefits.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.